The Alzheimer’s Drug Discovery Foundation (ADDF) has named Professor Miia Kivipelto, Scientific Coordinator of EU-FINGERS, as the recipient of the 2021 Melvin R. Goodes Prize. Introducing the award, Nancy Goodes said, “We are delighted to present this year’s Goodes Prize to Professor Kivipelto, whose monumental work with the FINGER trial has transformed how we view lifestyle interventions for Alzheimer’s prevention.”
Melvin R. Goodes Prize is an annual award given by the ADDF to leading researchers making important strides towards the development of effective treatments and a cure for Alzheimer’s.
The Goodes Prize includes a USD 150,000 award and will support Professor Kivipelto’s continued research on prevention, early diagnosis, and treatment of cognitive impairment, dementia, and Alzheimer’s disease.
“On behalf of my team and me, I am incredibly honored to receive such prestigious recognition. This award is especially significant as Mel Goodes, a prominent leader in the pharmaceuticals industry, and his work has positively impacted numerous patients. Receiving this award is an inspiration as we continue with our research into the prevention of Alzheimer’s. The award is also a great recognition for the AD prevention work and the multidomain FINGER model targeting several risk factors and mechanism at the same time. I believe that given the complex and multifactorial etiology of dementia and late-onset AD, this multidomain approach is needed to get an optimal preventive effect.”